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with no signiﬁcant difference in the rate of all-cause death, MI, UA,
coronary revascularization, or TIA/stroke (Table).
CONCLUSIONS In this “real-world”, retrospective, observational
study in ACS-PCI pts, physicians preferentially used prasugrel in
younger pts with lower risk of bleeding or comorbidities compared
with ticagrelor, although clinical outcomes associated with prasugrel
were noninferior to those associated with ticagrelor.Unmatched Matched
Prasugrel
N[12,797
Ticagrelor
N[2,991 p
Prasugrel
N[6,969
Ticagrelor
N[2,323 p
P-NI
(20%
margin)
n (%) n (%) n (%) n (%)
NACE 2,254
(17.6%)
593 (19.8%) 0.005 1,176
(16.9%)
446 (19.2%) 0.01 <0.0001
MACE 2,053
(16.0%)
542 (18.1%) 0.006 1,078
(15.5%)
405 (17.4%) 0.03 <0.0001
Rehospitalization for
bleeding
393 (3.1%) 99 (3.3%) 0.50 196 (2.8%) 76 (3.3%) 0.26 0.0005
All-cause death, MI, or
stroke
429 (3.4%) 117 (3.9%) 0.13 231 (3.3%) 89 (3.8%) 0.24 <0.0001
Coronary
Revascularization
1,432 (11.2%) 347 (11.6%) 0.52 728 (10.4%) 272 (11.7%) 0.09 <0.0001
CHF 481 (3.8%) 164 (5.5%) <0.001 265 (3.8%) 114 (4.9%) 0.02 <0.0001
NACE ¼ Net adverse clinical events; MACE ¼ Major adverse cardiac events; MI ¼ Myocardial infarction;
CHF ¼ congestive heart failure; NI ¼ Non-inferiorityCATEGORIES CORONARY: Acute Coronary Syndromes
KEYWORDS Outcomes research, Prasugrel, Ticagrelor
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BACKGROUND Spontaneous coronary artery dissection (SCAD) is a
rare and poorly understood cause of acute coronary syndrome (ACS)
and sudden cardiac death. It occurs predominantly in young women
who do not have risk factors for atherosclerosis, with an increased
proportion occurring in the peripartum period. The prevalence of
SCAD has been reported to range from 0.1% to 4% of ACS pre-
sentations. The purpose of this study is to evaluate the clinical char-
acteristics, management and outcomes of SCAD in a large
retrospective cohort of patients.
METHODS This study was conducted in the Northern California
Kaiser Permanente (KP) healthcare system using electronic databases
and medical charts. Coronary angiograms and, when available,
intravascular ultrasound from all potential SCAD cases were inde-
pendently reviewed by two interventional cardiologists. Healthy
controls with at least 9 months of KP enrollment prior to SCAD case
date were selected in a 3:1 ratio from the KP database, matching for
age, sex and follow up time from matched SCAD date. Major adverse
cardiovascular events (MACE) including recurrent SCAD, myocardial
infarction (MI), congestive heart failure hospitalization (CHF) and
death after the initial hospitalization were obtained during follow
up.
RESULTS 111 patients during 2003-2012 were identiﬁed as having
SCAD, 333 matching healthy controls were selected. The median
follow-up was 38 (range 7-119) months. SCAD patients had a mean age
of 48.1  11 years, 93% were female. 9 out of 103 (9%) women were
postpartum. 91% presented with acute myocardial infarction, 23% had
ST elevation on EKG. The left anterior descending artery was the most
frequently involved (72%) coronary artery. Precipitating emotional or
physical stress was reported in 12.6%. Fibromuscular dysplasia was
identiﬁed in 23% of femoral angiograms performed. 47% were suc-
cessfully treated conservatively without needing further revasculari-
zation. Among the 51% who had percutaneous coronary intervention
in-hospital, 2 required coronary artery bypass surgery for SCAD
extension. Hyperlipidemia and pregnancy were signiﬁcantly more
frequent in SCAD cases than controls. Among SCAD patients, MACE
occurred in 9% (0 deaths, 3 recurrent SCAD, 5 MI, 1 CHF) and among
the controls, MACE occurred in 1% (1 non cardiovascular related
death, 1 MI, 1 CHF). 47% SCAD patients had at least one repeatemergency room visit or hospitalization for troponin-negative chest
pain. 19 of 44 (43%) repeat angiographies were performed more than
20 days after initial SCAD, with 80% of them showing spontaneous
healing.
CONCLUSIONS SCAD affects predominantly young women, majority
presenting as acute myocardial infarction. Pregnancy and hyperlip-
idemia are more frequent in SCAD than controls. All patients treated
conservatively initially did not require revascularization. The SCAD
recurrence rate was very low and the mortality rate was zero. How-
ever there was a high rate of troponin-negative chest pain emergency
room visit or hospitalization during follow-up.
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BACKGROUND Subacute stent thrombosis (SST) (0 – 30 days) remains
an important complication post primary percutaneous intervention
(PPCI), with morbidity and mortality reaching those of spontaneous
myocardial infarction. To date, our information on angiographic and
clinical predictors of SST in ST- segment elevation myocardial
infarction (STEMI) patients treated with PPCI is limited. We tried to
analyse the clinical and angiographic predictors of SST in a large
cohort of STEMI patients treated with PPCI and coronary stent
deployment. Secondly, we wanted to assess if SST is associated with
higher 30-day mortality in the current era.
METHODS We identiﬁed all the patients presenting as STEMI be-
tween June 2004 and January 2011 who underwent PPCI with stent
deployment as the primary mode of revascularization. Diagnosis of
stent thrombosis was made as per the standard deﬁnition proposed
by the Academic Research Consortium (ARC). Patients were divided
into with and without SST. Patients in both groups were compared
for basic clinical and angiographic characteristics.
RESULTS A total of 2303 patients underwent PPCI with coronary stent
deployment. The overall rate of SST was 1% (n ¼ 24). Deﬁnite and
probable EST occurred in 22 and 2 patients respectively. All but 1
patient with SST had received bare metal stent. The baseline charac-
teristics of the patients are shown in Table 1. There was no signiﬁcant
difference between access site (transradial vs. femoral), type of
anticoagulant use (bivalirudin vs. heparin), aspiration
thrombectomy, use of GPIIbIIIa or the infarct related artery between
the two groups. Patients with SST had higher in-hospital (p ¼ 0.03)
and 30 day mortality (p ¼ 0.048). However, there was no signiﬁcant
difference in mortality at 6 months between the two groups. The
rate of cardiogenic shock (p ¼ 0.0006) and cerebrovascular accident
(p ¼ 0.0004) was higher in the SST group. On IVUS imaging of SST
cases, under deployment of stent and uncovered plaque area was
noted in nearly half of the cases.SST
(N[24)No SST
(N[2279) P ValueMen 20 (83%) 1670 (73%) 0.26Age (yrs) 59  11 61  13 0.37
Hypertension 9 (38%) 1076 (47%) 0.34Diabetes 2 (8%) 387 (17%) 0.26Hyperlipidemia 11 (46%) 884 (39%) 0.56Smoking 9 (38%) 965 (42%) 0.63Previous MI 2 (9%) 280 (12%) 0.54Previous CABG 0 73 (3%) 0.37BMI 28  5 27  4 0.21
Systolic BP (mmHg) 132  24 131  20 0.48
Hemoglobin (g/dl) 141  18 141  24 0.26
Creatinine (mmol/L) 96  53 96  34 0.96CONCLUSIONS Incidence of SST in PPCI cohort is around 1%. It is still
associated with higher mortality and cardiogenic shock. Under
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cause of SST.
CATEGORIES CORONARY: Acute Coronary Syndromes
KEYWORDS ST- Stent Thrombosis
TCT-174
Baseline hemoglobin level, anemia and adverse events in patients with
acute coronary syndromes; Lessons from ACUITY and HORIZONS-AMI
Sorin Brener,1 Roxana Mehran,2 Girma M. Ayele,3 Gregg W. Stone4
1New York Methodist Hospital, Brooklyn, NY; 2Icahn School of
Medicine at Mount Sinai, New York, United States; 3Cardiovascular
Research Foundation, New York, NY; 4Columbia University Medical
Center and the Cardiovascular Research Foundation, New York, United
States
BACKGROUND The association between anemia at admission and
adverse outcome in patients with acute coronary syndromes (ACS) has
been recently emphasized. A more granular analysis between baseline
hemoglobin and adverse events has not been reported.
METHODS Anemia was deﬁned as serum hemoglobin <12 g/dl in
women and <13 g/dl in men in two large ACS trials – ACUITY and
HORIZONS-AMI. We plotted gender–speciﬁc hazard functions for all-
cause mortality at 1 year and major bleeding at 30 days according to
baseline hemoglobin, and analyzed time to events according to ter-
tiles of hemoglobin.
RESULTS Among 16,421 patients, 2,558 (15.6%) had anemia at base-
line. Patients with anemia were older, more often women, and had
higher rates of CAD risk factors. They were also signiﬁcantly more
likely not to undergo revascularization. The hemoglobin level on
admission was 11.71.0 g/dl in anemic and 14.61.2 g/dl in non-
anemic patients (P<0.001). The incidence of ischemic events in the
two groups is shown in Table 1. Death and MI were signiﬁcantly more
common in anemic patients at 30 days and at 1 year, while rates of ST,
TLR and TVR were similar. Non-CABG major bleeding was 2x as
common in the anemic patients (8.4% vs. 3.6%, P<0.001), and
transfusions were administered 5x more often (7.5% vs. 1.5%,
P<0.001). Patients in the highest tertile of hemoglobin (>14.8 g/dl)
has the lowest 1-year mortality, compared with the middle tertile
(13.5-14.8 g/dl) and lowest tertile (<13.5 g/dl): 3.0% vs. 3.4% vs.
5.8%, P<0.0001, respectively. There was no signiﬁcant difference
between the middle and highest tertile of baseline hemoglobin
(P¼0.08). Gender-speciﬁc spline transformations of the hazard for
death at 1 year as a function of hemoglobin level on admission
showed that the lowest mortality was observed at a baseline
hemoglobin level of 14.6 g/dl for men and 13.2 g/dl for women.
Below and above these levels mortality increased (U-shaped curve).
The lowest rate of major bleeding events occurred at similar
hemoglobin levels as for mortality.
CONCLUSIONS Baseline hemoglobin carries important prognostic
information and appears to have a non-linear association with both
death and major bleeding events. The risk for mortality and major
bleeding increases with hemoglobin levels below and above 14.6 g/dl
for men and 13.2 g/dl for women.Anemia No Anemia p value30 DAY EVENTSDeath 3.1% (78) 1.5% (203) <0.0001Reinfarction 5.5% (139) 4.3% (593) 0.008Death or reinfarction 7.9% (201) 5.5% (757) <0.0001Deﬁnite stent
thrombosis0.4% (11) 0.8% (103) 0.08Target vessel
revascularization1.2% (30) 1.6% (221) 0.111-YEAR EVENTSDeath 7.4% (184) 3.5% (442) <0.0001Reinfarction 8.5% (203) 6.4% (857) 0.0005Death or reinfarction 14.7% (359) 9.2% (1212) <0.0001Deﬁnite stent
thrombosis0.8% (19) 1.2% (156) 0.09Target vessel
revascularization5.8% (137) 5.7% (725) 0.63CATEGORIES CORONARY: Acute Coronary Syndromes
KEYWORDS Adverse events, Anemia
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BACKGROUND The temporal changes in the clinicopathological
characteristics of cardiac rupture (CR) are ill-deﬁned.
METHODS 187 consecutive decedents with acute myocardial infarc-
tion (AMI) and fatal CR of the left ventricular free wall and/or septum
whose autopsies were performed at Mayo Clinic between 1986 and
2012 were included and their clinical and autopsy characteristics were
studied. Overall autopsies were divided into three groups: group 1
(N¼100) (1986-1995); (N¼49) group 2, (1996-2004); and group 3 (N¼38)
(2005-2012).
RESULTS Median age of decedents at CR did not change from be-
tween the 3 groups (76, 76, 72; p¼0.35), however, the prevalence of
hypertension and prior MI decreased with time. The most common
clinical and anatomical site of CR in groups 2 and 3 were at the edge of
an inferolateral infarct (Fig 1). Median infarct age remained the same
(Table 1). Plaque rupture was seen less commonly, however, severe
atherosclerosis was more prevalent in groups 2 and 3.
Table 1VariableGroup 1
(N[100)Group 2
(N[49)Group 3
(N[38) PAge, median 76 76 72 0.35Men 49% 55% 53% 0.77Hypertension 72% 65% 50% 0.12Diabetes 21% 31% 21% 0.53Smoking history 31% 56 55% 0.026Prior MI 22% 15% 0 0.07Presentation with chest pain 75% 77% 40% 0.0073 vessels with Grade 4 atherosclerosis 29% 43% 51% 0.035Plaque rupture not seen 19% 48% 74% <0.001Acute thrombus 80% 70% 66% 0.21Infarct site0.14
- Anterior 45% 33% 26%- Inferior 35% 41% 37%- Lateral 19% 27% 37%Median infarct age, days 4 3.5 4 0.08Rupture Site with Infarct0.52Central 32% 43% 42%Peripheral 65% 57% 58%
